Demographic characteristics and global assessment of the HD patients.

HD1: patients at Stage 1, HD2: patients at Stage 2; TFC: Total Functional Capacity; UHDRS: United Huntington Disease Rating Scale; MDRS: Mattis Dementia Rating Scale; FCSRT: Free and Cued Selective Reminding Test; RAVLT: Rey Auditory Verbal Learning Task; TMT-A; Trail Making Test form A; TMT-B: Trail Making Test form B; Stroop C/W: Stroop Color Interference Test; MCST: Modified Card Sorting Test; MADRS: Montgomery and Åsberg Depression Rating Scale; ns: non significant.a: 17/25;b: 18/21;c: 19/25;d: 14/21;e: 15/25;f: 15/21;g: 24/25;h: 20/21.*cut-off are provided according to [21].

HD1：1期亨廷顿病患者；HD2：2期亨廷顿病患者；TFC：总功能能力（Total Functional Capacity）；UHDRS：联合亨廷顿病评定量表（United Huntington Disease Rating Scale）；MDRS：马特利斯痴呆评定量表（Mattis Dementia Rating Scale）；FCSRT：自由提示选择性提醒测验（Free and Cued Selective Reminding Test）；RAVLT：雷伊听觉词语学习测验（Rey Auditory Verbal Learning Task）；TMT-A：连线测验A版（Trail Making Test form A）；TMT-B：连线测验B版（Trail Making Test form B）；Stroop C/W：斯特鲁普色词干扰测验（Stroop Color Interference Test）；MCST：改良卡片分类测验（Modified Card Sorting Test）；MADRS：蒙哥马利-阿斯伯格抑郁评定量表（Montgomery and Åsberg Depression Rating Scale）；ns：无统计学显著性（non significant）。a：17/25；b：18/21；c：19/25；d：14/21；e：15/25；f：15/21；g：24/25；h：20/21。*临界值参照文献[21]制定。